Baxter Total Liabilities 2010-2025 | BAX
Baxter total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Baxter total liabilities for the quarter ending March 31, 2025 were $14.250B, a 27.12% decline year-over-year.
- Baxter total liabilities for 2024 were $18.758B, a 5.3% decline from 2023.
- Baxter total liabilities for 2023 were $19.808B, a 11.54% decline from 2022.
- Baxter total liabilities for 2022 were $22.392B, a 8.23% decline from 2021.
| Baxter Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $18,758 |
| 2023 | $19,808 |
| 2022 | $22,392 |
| 2021 | $24,400 |
| 2020 | $11,293 |
| 2019 | $10,281 |
| 2018 | $7,854 |
| 2017 | $7,995 |
| 2016 | $7,266 |
| 2015 | $12,097 |
| 2014 | $17,982 |
| 2013 | $16,738 |
| 2012 | $13,412 |
| 2011 | $12,245 |
| 2010 | $10,693 |
| 2009 | $9,934 |
| Baxter Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $14,250 |
| 2024-12-31 | $18,758 |
| 2024-09-30 | $18,734 |
| 2024-06-30 | $18,604 |
| 2024-03-31 | $19,553 |
| 2023-12-31 | $19,808 |
| 2023-09-30 | $22,490 |
| 2023-06-30 | $22,254 |
| 2023-03-31 | $22,350 |
| 2022-12-31 | $22,392 |
| 2022-09-30 | $22,386 |
| 2022-06-30 | $22,928 |
| 2022-03-31 | $23,597 |
| 2021-12-31 | $24,400 |
| 2021-09-30 | $10,992 |
| 2021-06-30 | $11,147 |
| 2021-03-31 | $10,976 |
| 2020-12-31 | $11,293 |
| 2020-09-30 | $11,496 |
| 2020-06-30 | $11,305 |
| 2020-03-31 | $11,345 |
| 2019-12-31 | $10,281 |
| 2019-09-30 | $9,682 |
| 2019-06-30 | $9,708 |
| 2019-03-31 | $8,681 |
| 2018-12-31 | $7,854 |
| 2018-09-30 | $7,734 |
| 2018-06-30 | $7,709 |
| 2018-03-31 | $7,797 |
| 2017-12-31 | $7,995 |
| 2017-09-30 | $8,082 |
| 2017-06-30 | $7,798 |
| 2017-03-31 | $6,984 |
| 2016-12-31 | $7,266 |
| 2016-09-30 | $7,131 |
| 2016-06-30 | $7,472 |
| 2016-03-31 | $8,330 |
| 2015-12-31 | $12,097 |
| 2015-09-30 | $12,327 |
| 2015-06-30 | $21,994 |
| 2015-03-31 | $17,573 |
| 2014-12-31 | $17,982 |
| 2014-09-30 | $17,137 |
| 2014-06-30 | $16,942 |
| 2014-03-31 | $16,568 |
| 2013-12-31 | $16,738 |
| 2013-09-30 | $17,504 |
| 2013-06-30 | $16,436 |
| 2013-03-31 | $13,317 |
| 2012-12-31 | $13,412 |
| 2012-09-30 | $12,635 |
| 2012-06-30 | $11,834 |
| 2012-03-31 | $11,820 |
| 2011-12-31 | $12,245 |
| 2011-09-30 | $10,653 |
| 2011-06-30 | $10,497 |
| 2011-03-31 | $10,442 |
| 2010-12-31 | $10,693 |
| 2010-09-30 | $10,800 |
| 2010-06-30 | $10,353 |
| 2010-03-31 | $10,507 |
| 2009-12-31 | $9,934 |
| 2009-09-30 | $9,643 |
| 2009-06-30 | $8,969 |
| 2009-03-31 | $8,795 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.457B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |